1. Home
  2. LPCN vs FOFO Comparison

LPCN vs FOFO Comparison

Compare LPCN & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.10

Market Cap

18.7M

Sector

Health Care

ML Signal

HOLD

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

HOLD

Current Price

$2.16

Market Cap

19.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPCN
FOFO
Founded
1997
2017
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
19.2M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
LPCN
FOFO
Price
$2.10
$2.16
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.2K
★ 177.3K
Earning Date
05-07-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,976,677.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$92.00
N/A
P/E Ratio
★ N/A
$11.09
Revenue Growth
N/A
★ N/A
52 Week Low
$1.81
$1.70
52 Week High
$12.37
$68.00

Technical Indicators

Market Signals
Indicator
LPCN
FOFO
Relative Strength Index (RSI) 38.84 52.24
Support Level $2.00 $1.76
Resistance Level $2.27 $2.79
Average True Range (ATR) 0.09 0.22
MACD -0.02 0.04
Stochastic Oscillator 0.00 44.17

Price Performance

Historical Comparison
LPCN
FOFO

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

Share on Social Networks: